Ulrich Reinhold Speck
Chief Tech/Sci/R&D Officer at ACOTEC SCIENTIFIC HOLDINGS LIMITED
Profile
Ulrich Reinhold Speck is the founder of InnoRa GmbH, which was founded in 2001.
He held the title of Managing Director & Legal Representative from 2001 to 2017.
Currently, he is the Chief Technology Officer at Acotec Scientific Holdings Ltd.
since 2021.
Previously, he worked as a Professor at Charité - Universitätsmedizin Berlin from 2000 to 2001.
Dr. Speck received his doctorate degree from Freie Universität Berlin in 1967.
Ulrich Reinhold Speck active positions
| Companies | Position | Start |
|---|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Chief Tech/Sci/R&D Officer | 2021-01-28 |
Former positions of Ulrich Reinhold Speck
| Companies | Position | End |
|---|---|---|
InnoRa GmbH
 InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Founder | 2017-01-17 |
| Charité - Universitätsmedizin Berlin | Corporate Officer/Principal | 2000-12-31 |
Training of Ulrich Reinhold Speck
| Freie Universität Berlin | Doctorate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ACOTEC SCIENTIFIC HOLDINGS LIMITED | Health Technology |
| Private companies | 1 |
|---|---|
InnoRa GmbH
InnoRa GmbH Medical/Nursing ServicesHealth Services InnoRa GmbH is a German company that specializes in randomized clinical trials and contributions to product development. The private company is based in Berlin, Germany. The company focuses on developing coated balloons, devices, and therapeutics for restenosis inhibition by non-stent-based local drug delivery. In addition, they conduct clinical trials and research in pharmacology, pharmacokinetics, bioanalytics, relaxometry, and molecular imaging. The company was founded in 2001 by Ulrich Reinhold Speck. Thomas Speck has been the CEO of the company since 2011. | Health Services |
- Stock Market
- Insiders
- Ulrich Reinhold Speck
